Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine and High-Dose Chemotherapy in AML and CML
NCT00003407Phase 2Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- Feb 2001
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amifostine in acute myeloid leukemia (AML), chronic myelogenous leukemia (CML), sponsored by Rush University Medical Center. Planned start Feb 2001; status: withdrawn.
02
Drugs
amifostine
03
Conditions
acute myeloid leukemia (AML)chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NCT00003407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003407.